News PharmAla Biotech receives guidance on new MDMA-like drug for PTSD and Autism The MHRA has confirmed that PharmAla's MDMA-like drug candidate ALA-002 does not require additional preclinical data Natalia Buendia CalvilloJuly 20, 2023
Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023
Psychedelics MindBio Therapeutics receives approval for LSD study for major depression The study has been approved by the Clinical Trials Registry Rowan DunneMay 24, 2023
Cannabis SciSparc conducts CBD oil clinical trial for children with autism The trial will be held at the Soroka University Medical Center in Be'er Sheva, Israel Rowan DunneMarch 1, 2023
Psychedelics Optimi Health submits clinical trial application after developing proprietary MDMA drug The drug will be used to help establish a safe supply for patients in Canada and Australia Rowan DunneFebruary 7, 2023
Psychedelics Woke Pharma and Swinburne U partner for Australia’s biggest psilocybin trial The AUD$5M study will involve about 160 participants and aims to help combat treatment-resistant depression Rowan DunneFebruary 1, 2023
Canada Health Canada provides guidance for clinical trials on psychedelics The notice to stakeholders outlined risk management and consent expectations for the study of psychoactive drugs Rowan DunneDecember 5, 2022
Health & Wellness ChitogenX completes opening phases of rotator cuff clinical trial ChitogenX is a clinical stage regenerative medicine company developing therapeutic tissue repair technologies. Joseph MortonNovember 9, 2022
Psychedelics Small Pharma gets approval for upcoming injectable DMT trial on humans New phase I study will be held at MAC Clinical Research in Manchester, England next year Rowan DunneOctober 31, 2022
Medical and Pharmaceutical The Mugglehead technology roundup: medical tech and biotechnology edition Here are five biotechnology and medical tech companies pooling their resources to make our lives easier. Joseph MortonOctober 14, 2022